Evidence map›Paper›PMID 39188413›Full record

ArticleContemporary clinical trials communications2024

Maximizing the reach of universal child sexual abuse prevention: Protocol for an equivalence trial.

Kate Guastaferro, Mia S Melchior, Siyu Heng, Jessica Trudeau, Jacqueline L Holloway

Registry-linked trialAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06195852 (Maximizing the Reach of Universal Child Sexual Abuse Prevention), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06195852 naterminatednot on this map

Maximizing the Reach of Universal Child Sexual Abuse Prevention: An Equivalence Trial

TypeinterventionalSponsorNew York UniversityRan2024 to 2025Enrolled26ConditionsChild Sexual AbuseArmsUsual Safe Touches, Modified Safe Touches
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kate GuastaferroDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, 708 Broadway, 6th Floor Room 636, New York, NY, 10003, USA.
Mia S MelchiorDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, 708 Broadway, 6th Floor Room 636, New York, NY, 10003, USA.
Siyu HengDepartment of Biostatistics, School of Global Public Health, New York University, 708 Broadway, 7th Floor Room 743, New York, NY, 10003, USA.
Jessica TrudeauNew York Society for the Prevention of Cruelty to Children, 520 8 Avenue Suite 1401, New York, NY, 10018, USA.
Jacqueline L HollowayNew York Society for the Prevention of Cruelty to Children, 520 8 Avenue Suite 1401, New York, NY, 10018, USA.

Funding

Maximizing the reach of universal child sexual abuse prevention: An equivalence trialR21HD110822 · NICHD · NEW YORK UNIVERSITY · PI GUASTAFERRO, KATELYN · 2023 to 2023
$400k
NICHD NIH HHS R21 HD110822
6 · The paper itself

Abstract

Background: Child sexual abuse (CSA) affects 1 in 5 girls and 1 in 12 boys before age 18. Universal school-based prevention programs are an effective and cost-efficient method of teaching students an array of personal safety skills. However, the programmatic reach of universal school-based programs is limited by the inherent reliance on the school infrastructure and a dearth of available alternative delivery modalities. Methods: The design for this study will use a rigorous cluster randomized design ( Conclusion: Study findings will inform the ongoing development of effective CSA prevention programs and policy decisions regarding the sustainable integration of such programs within schools. Clinical trial registration: NCT06195852.

Indexed as

Child sexual abuseDissemination and implementationSchool-based prevention

Identifiers

PMID39188413
PMCPMC11345503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.